Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

Seven Hot Stocks From Hot Fund Managers

Nov 27 2019 - FYI

Peter Switzer of the Switzer Report attended the recent Sohn Hearts & Minds conference for some investment tips.


Brokers Welcome Caltex Plans For Retail IPO

Nov 26 2019 - Australia

Brokers welcome the potential for a future capital return as Caltex announces plans to spin off an interest in most of its freehold retail property.


Bank Of Queensland Recovery Likely Long-Dated

Nov 26 2019 - Australia

Bank of Queensland may have announced a capital raising to shore up its balance sheet and provide the flexibility to improve operations but brokers are not that impressed.


BHP Group Resumes Uptrend

Nov 26 2019 - Technicals

Michael Gable of Fairmont Equities notes BHP Group is making higher lows and higher highs.


Monthly Listed Investment Trust Report – Nov 2019

Nov 26 2019 - FYI

Independent Investment Research updates developments in Australia’s listed investment trust market and provides comparative data.


RESEARCH: Real Energy Corp, The New Normal

Nov 26 2019 - FYI

Pitt Street Research has initiated coverage of unconventional energy play, Real Energy Corp


Metcash Under Scrutiny After Losing 7-Eleven

Nov 25 2019 - Australia

Grocery wholesaler Metcash has lost its second major contract in 18 months, exacerbating speculation around the scale and sustainability of the company’s distribution channel.


Mayne Pharma Aspires To Specialisation

Nov 25 2019 - Australia

Mayne Pharma aspires to have more than 60% of its FY24 revenue from US specialty products, although significant challenges in generics are likely to beset the business in the interim.


FNArena Corporate Results Monitor – 25-11-2019

Nov 25 2019 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.


RESEARCH: Funding Boost For Sensera

Nov 25 2019 - FYI

Pitt Street Research updates on Sensera’s new funding package


Analyse The Market From A Different Angle